Share Facebook Twitter LinkedIn Pinterest Email Alnylam reports positive Phase 2 data for hypertension drug
Tenon Medical outlines growth acceleration plans following 92% Q4 revenue jump and expanded SI-Joint Fusion portfolio (NASDAQ:TNON)March 19, 2026